J
Jens Greve
Researcher at University of Düsseldorf
Publications - 7
Citations - 624
Jens Greve is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Angioedema & Randomized controlled trial. The author has an hindex of 5, co-authored 7 publications receiving 553 citations.
Papers
More filters
Journal ArticleDOI
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
Marco Cicardi,Aleena Banerji,F. Bracho,Alejandro Malbrán,Bernd Rosenkranz,Marc A. Riedl,Konrad Bork,William R. Lumry,Werner Aberer,Henning Bier,Murat Bas,Jens Greve,Thomas K. Hoffmann,Henriette Farkas,Avner Reshef,Bruce Ritchie,William H. Yang,Jürgen Grabbe,Shmuel Kivity,Wolfhart Kreuz,Robyn J. Levy,Thomas A. Luger,Krystyna Obtułowicz,Peter Schmid-Grendelmeier,Christian Bull,Brigita Sitkauskiene,William B Smith,Elias Toubi,Sonja Werner,Suresh Anné,Janne Björkander,Laurence Bouillet,Enrico Cillari,D. Hurewitz,Kraig W. Jacobson,Constance H. Katelaris,Marcus Maurer,Hans F. Merk,Jonathan A. Bernstein,Conleth Feighery,Bernard Floccard,Gerald J. Gleich,Jacques Hébert,Martin Kaatz,Paul K. Keith,Charles H. Kirkpatrick,David Langton,Ludovic Martin,Christiane Pichler,David Resnick,Duane Wombolt,Diego S. Fernández Romero,Andrea Zanichelli,Francesco Arcoleo,Jochen Knolle,Irina Kravec,Liying Dong,Jens Zimmermann,Kimberly Rosen,Wing Tze Fan +59 more
TL;DR: In patients with hereditary angioedema having acute attacks, a significant benefit of icatibant as compared with tranexamic acid in one trial and a nonsignificantbenefit of ic atibant in the other trial are found with regard to the primary end point.
Journal ArticleDOI
Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis.
Kathrin Scheckenbach,Oliver A. Cornely,Thomas K. Hoffmann,Rainer Engers,Henning Bier,A. Chaker,Jens Greve,Jörg Schipper,Martin Wagenmann +8 more
TL;DR: RSM remains a diagnostic and therapeutic challenge because it begins with nonspecific symptoms and ends as fulminant disease with high mortality, and systemic treatment with Posaconazole appears to be a more effective alternative to amphotericin.
Journal ArticleDOI
Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema.
Murat Bas,Thomas K. Hoffmann,Bernd Tiemann,Vu Thao-Vi Dao,Christos Bantis,Vera Balz,Hans-Jürgen Schultz-Coulon,Thomas Stark,Patrick J. Schuler,Jens Greve,Katrin Ivens,Henning Bier,Georg Kojda +12 more
TL;DR: The data suggest that polymorphism of ACE I/D and the bradykinin B2 receptor polymorphisms are not involved in the development of ACEi-induced angio-oedema when considered individually.
Journal ArticleDOI
Surgical management of retropharyngeal abscesses
Patrick J. Schuler,Mathias Cohnen,Jens Greve,C Plettenberg,Jimmy Chereath,Murat Bas,Caroline Koll,Kathrin Scheckenbach,Martin Wagenmann,Joerg Schipper,Thomas K. Hoffmann +10 more
TL;DR: Retropharyngeal abscess is a rare, potentially life-threatening disease, requiring appropriate otorhinolaryngologic as well as radiologic diagnostics, and medical and surgical intervention by a transoral, transcervical or transnasal approach in a multidisciplinary setting.
Journal ArticleDOI
Ulmer Notfallalgorithmus: die Akuttherapie von medikamenteninduzierten bradykininvermittelten Angioödemen
Janina Hahn,Bastian Bock,Claus-Martin Muth,Anja Pfaue,Daniel T. Friedrich,Thomas K. Hoffmann,Jens Greve +6 more
TL;DR: Bradykinin-mediated, drug-induced edema like ACE-inhibitor-induced angioedema (ACEi AE) is almost exclusively located in the head and neck region and is potentially life threatening.